Literature DB >> 10637653

Integrin cell adhesion receptors and the concept of agonism.

M J Humphries1.   

Abstract

Most cells are adherent and rely on adhesive interactions to regulate their shape, motility and growth. These interactions are critical for tissue integrity and homeostasis but they also contribute to many of the most common diseases in humans. The integrins are a key family of cell-surface receptors that mediate the downstream consequences of cell adhesion and are therefore prime targets for the development of therapeutic agents. In addition to their adhesive activity, integrins also exhibit several other classical features of signalling receptors. Sufficient evidence is now available to pose the question of whether integrins should be classified as true signalling receptors; this article both reviews this evidence and attempts to identify remaining gaps.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10637653     DOI: 10.1016/s0165-6147(99)01410-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  12 in total

1.  Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5.

Authors:  Barbara Salone; Yuri Martina; Stefania Piersanti; Enrico Cundari; Gioia Cherubini; Laure Franqueville; Cristina M Failla; Pierre Boulanger; Isabella Saggio
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion.

Authors:  Guillermo Petrini; Elena J Ochoa; Esteban Serra; Adriana M Torres; M Monica Elías
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

3.  Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway.

Authors:  C Soudais; S Boutin; S S Hong; M Chillon; O Danos; J M Bergelson; P Boulanger; E J Kremer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Dual functionality of the anti-beta1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors.

Authors:  Jonathan D Humphries; Neil R Schofield; Zohreh Mostafavi-Pour; Linda J Green; Alistair N Garratt; A Paul Mould; Martin J Humphries
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

5.  Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation.

Authors:  S J Yarwood; J R Woodgett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

Review 6.  Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.

Authors:  Shlomo Rotshenker
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 7.  Interferon-alpha and the pathogenesis of myeloproliferative disorders.

Authors:  I A Voutsadakis
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.738

8.  Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.

Authors:  Susanna W L de Geus; Leonora S F Boogerd; Rutger-Jan Swijnenburg; J Sven D Mieog; Willemieke S F J Tummers; Hendrica A J M Prevoo; Cornelis F M Sier; Hans Morreau; Bert A Bonsing; Cornelis J H van de Velde; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

Review 9.  Molecular Imaging of Angiogenesis in Cardiac Regeneration.

Authors:  Ljubica Mandic; Denise Traxler; Alfred Gugerell; Katrin Zlabinger; Dominika Lukovic; Noemi Pavo; Georg Goliasch; Andreas Spannbauer; Johannes Winkler; Mariann Gyöngyösi
Journal:  Curr Cardiovasc Imaging Rep       Date:  2016-09-10

Review 10.  Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators.

Authors:  Alessandra Tolomelli; Paola Galletti; Monica Baiula; Daria Giacomini
Journal:  Cancers (Basel)       Date:  2017-07-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.